Researchers Resolved Mycobacterium Tuberculosis Enzyme Structures
Scientists utilized cryo-EM to determine the architecture of pyruvate carboxylase in the pathogen.
Updated on Oct. 6, 2026 in Biotech
Researchers have successfully resolved four cryo-EM structures of the biotin-dependent enzyme pyruvate carboxylase found in Mycobacterium tuberculosis. These structures provide new insights into how the enzyme functions in both apo and acetyl-CoA-bound states.
Why it matters
Pyruvate carboxylase is essential for the intracellular survival and anaplerotic metabolism of Mycobacterium tuberculosis. Mapping its structure is a critical step in understanding the metabolic pathways that sustain the pathogen.
The study successfully resolved four unique cryo-EM structures, identifying a compact tetrameric architecture stabilized by acetyl-CoA binding. Analysis utilized advanced methods including symmetry expansion, focused classification, and local refinement.
The players
Mycobacterium tuberculosis
This is the pathogenic bacterium responsible for causing tuberculosis in humans.
The details
The enzyme adopts a heterogeneous expanded assembly when acetyl-CoA is absent but transitions to a stable, compact tetrameric form when the molecule is bound. Researchers also identified a reciprocal interfacial seam between PT domains, with the BCCP domain engaging at both catalytic centers.
Timeline
October 6, 2026: The research findings were published.
The Big Picture
This research follows a pattern set by the ongoing structural biology investigation of metabolic enzymes in Mycobacterium tuberculosis. The study updates our understanding of the pathogen's machinery by providing the first detailed look at the pyruvate carboxylase assembly.
This discovery provides researchers with the mechanical blueprints necessary to target the pathogen at a molecular level. These structural insights could eventually accelerate the development of new treatments for tuberculosis.
The takeaway
Understanding the structural shifts in bacterial enzymes provides a foundation for more effective drug targeting. These findings demonstrate how specific metabolic switches like acetyl-CoA can lock essential proteins into vulnerable conformations.
Further reading
Learn more about the latest developments in Biotech.
More information
Read the complete peer-reviewed research article for technical data.
Source note: This article includes information reported by Nature.
